Varenicline is a medicine that is used in smoking cessation. It binds with nicotine acetylcholine receptors and has partial agonist effects when used alone and antagonist activities when used with nicotine.
Varenicline can successfully hinder nicotine’s activity to completely activate α4β2 receptors and the mesolimbic dopamine system, which is responsible for the reward experienced after smoking.